DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Canada
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
NAV logo

NAVCO Pharmaceuticals Inc. Stock Price

TSXV:NAV Community·CA$285.3k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

NAV Share Price Performance

CA$0.005
0.00 (0.00%)
​
CA$0.005
0.00 (0.00%)
​
Price CA$0.005
Fri, 11 Sep 26
Share Pricen/a

NAV Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
1 Reward
View Full Analysis

NAVCO Pharmaceuticals Inc. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$68.8k

Other Expenses

-CA$68.8k

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.0012
0%
0%
-11.5%
View Full Analysis

About NAV

Founded
n/a
Employees
n/a
CEO
Geoffrey Lee
WebsiteView website
navcopharma.com

NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms. NAVCO Pharmaceuticals Inc. is headquartered in Vancouver, Canada.

Recent NAV News & Updates

Recent updates

No updates

NAVCO Pharmaceuticals Inc. Competitors

AQS logo

Aequus Pharmaceuticals

Symbol: TSXV:AQS
Market cap: CA$663.2k
PHRX logo

Pharmadrug

Symbol: CNSX:PHRX
Market cap: CA$671.1k
TMED.X logo

EGF Theramed Health

Symbol: CNSX:TMED.X
Market cap: CA$638.9k
VXL

Vaxil Bio

Symbol: TSXV:VXL
Market cap: CA$637.4k
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide